Sentinel lymph node metastasis in anal melanoma: A case report

International Journal of Gastrointestinal Cancer

Volumn 32, Issue 1, 2002, Pages 53-56

  Tien, Huey Y ^a   McMasters, Kelly M ^a   Edwards, Michael J ^a   Chao, Celia ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Anal melanoma; Anorectal melanoma; Biochemotherapy; Sentinel lymph node; Sentinel node metastasis

Indexed keywords

ADULT; ANUS TUMOR; ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE; SURVIVAL; ULTRAVIOLET B RADIATION;

ADULT; ANUS NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COLORING AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM PROTEINS; NEOPLASM STAGING; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; ROSANILINE DYES; S100 PROTEINS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0036938826     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Weinstock MA. Epidemiology and prognosis of anorectal melanoma. Gastroenterology 1993;104:174-178.
2. Lew RA, Sober AJ, Cook N, et al. Sun exposure habits in patients with cutaneous melanoma: a case control study. J Dermatol Surg Oncol 1983;9:981-986.
3. Thibault D, Sagar P, Nivatvongs S Anorectal melanomaan incurable disease? Dis Colon Rectum 1997;40:661-668.
4. Slingluff CL Jr, Vollmer RT, Seigler HFF. Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery 1990;107:1-9.
5. Goldman S, Glimelius B, Pahlman L. Anorectal malignant melanoma in Sweden: report of 49 patients. Dis Colon Rectum 1990;33:374-377.
6. Cooper PH, Mills SE, Allen MS Jr. Malignant melanoma of the anus: report of 12 patients and analysis of 255 additional cases. Dis Colon Rectum 1982;25:693-703.
7. Coit DG. Role of surgery for metastatic malignant melanoma: a review. Semin Surg Oncol 1993;9:239-245.
8. Chiu YS, Unni KK, Beart RW, Jr. Malignant melanoma of the anorectum. Dis Colon Rectum 1980;23:122-124.
9. Baas PC, Schraffordt Koops H, Hoekstra HJ, et al. Groin dissection in the treatment of lower-extremity melanoma: short-term and long-term morbidity. Arch Surg 1992;127:281-286.
10. Yu LL, Flott TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999;86:617-627.
11. Gibbs JF, Huang PP, Zhang PJ, et al. Accuracy of pathologic techniques for the disgnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol 1999;6:699-704.
12. Brady MS, Kavolius JP, Quan SH. Anorectal melanoma: a 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum 1995;38:146-151.
13. Garnick M, Lokich JJ. Primary malignant melanoma of the rectum: rationale for conservative surgical management. J Surg Oncol 1978;10:529-531.
14. Soong SJ, Shaw HM, Balch CM, et al. Predicting survival and recurrence in localized melanoma: a multivariate approach. World J Surg 1992;16:191-195.
15. Wanebo HJ, Woodruff JM, Farr GH, et al. Anorectal melanoma. Cancer 1981;47:1891-1900.
16. Legha SS, Ring S, Eton O, Bedikian A, Buzaid AC, Plager C, Papadopoulos N. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. J Clin Oncol 1998;16:1752-1759.
17. Kirkwood JM, Ibrahim JG, Sondak VK, et al. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol 2000;18:2444-2458.
18. Kirkwood JM, Ibrahim JG, Sosman JA, et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol 2001;19:2370-2380.